Journal of Oncology

Tumor Angiogenesis


Publishing date
01 May 2010
Status
Published
Submission deadline
01 Nov 2009

1Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA

2Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA

3Department of Biochemistry and Molecular Biology, Tumor Angiogenesis, Vascular Biology and Nanotechnology Laboratory, Mayo Clinic Foundation, Rochester, MN, USA


Tumor Angiogenesis

Description

For most cancers, if not all, angiogenesis is considered crucial for the progression of a localized tumor into an invasive cancer. Therapeutics targeting angiogenesis have been used successfully for the treatment of breast cancer, lung cancer, kidney cancer, and colon cancer. Recent reports, however, have provided evidence that clinical resistance to antiangiogenic agents can develop and that initial responses to these agents can lead to the development of more aggressive tumors. Early observations also indicate that lymphangiogenesis could promote tumor progression and pose a major challenge to the treatment of cancer with antiangiogenic therapy. The Journal of Oncology is, therefore, issuing an invitation to publish original research articles as well as review articles focusing on tumor vascularization and development of novel strategies targeting tumor angiogenesis and lymphangiogenesis.

Potential topics include but are not limited to:

  • Mechanisms contributing to the initial angiogenic switch in tumors
  • Influence of the tumor microenvironment on angiogenesis
  • Pericytes and vessel maturation in tumor angiogenesis
  • Molecular mechanisms of resistance to tumor antiangiogenic strategies
  • Tumor lymphangiogenesis as a potential therapeutic target
  • Role of lymphangiogenesis in tumor progression and resistance to antiangiogenic therapy
  • Mechanisms contributing to the development of aggressive tumors failing antiangiogenic therapy
  • Biological markers for predicting clinical response to antiangiogenic strategies
  • Radiological markers of tumor response
  • Mathematical models of the evolution of tumor vascularization
  • Antiangiogenic and vascular disrupting agents

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jo/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2010
  • - Article ID 509329
  • - Research Article

An Active Form of Sphingosine Kinase-1 Is Released in the Extracellular Medium as Component of Membrane Vesicles Shed by Two Human Tumor Cell Lines

Salvatrice Rigogliuso | Chiara Donati | ... | Maria Letizia Vittorelli
  • Special Issue
  • - Volume 2010
  • - Article ID 539706
  • - Review Article

Sympathetic Neurotransmitters and Tumor Angiogenesis—Link between Stress and Cancer Progression

Jason Tilan | Joanna Kitlinska
  • Special Issue
  • - Volume 2010
  • - Article ID 201026
  • - Review Article

Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation

Michael C. Schmid | Judith A. Varner
  • Special Issue
  • - Volume 2010
  • - Article ID 317068
  • - Review Article

TGF-β Superfamily Receptors—Targets for Antiangiogenic Therapy?

Jasmin Otten | Carsten Bokemeyer | Walter Fiedler
  • Special Issue
  • - Volume 2010
  • - Article ID 659231
  • - Research Article

Role of Angiopoietin-2 in Regulating Growth and Vascularity of Astrocytomas

Gelareh Zadeh | Keyvan Koushan | ... | Abhijit Guha
  • Special Issue
  • - Volume 2010
  • - Article ID 817375
  • - Research Article

IL-17B Can Impact on Endothelial Cellular Traits Linked to Tumour Angiogenesis

Andrew J. Sanders | Xiaoxia Guo | ... | Wen G. Jiang
  • Special Issue
  • - Volume 2010
  • - Article ID 723798
  • - Review Article

Peptide-Mediated Liposomal Drug Delivery System Targeting Tumor Blood Vessels in Anticancer Therapy

Han-Chung Wu | De-Kuan Chang
  • Special Issue
  • - Volume 2010
  • - Article ID 767384
  • - Review Article

The Role of Ets Factors in Tumor Angiogenesis

Peter Oettgen
  • Special Issue
  • - Volume 2010
  • - Article ID 396286
  • - Research Article

Architectural Heterogeneity in Tumors Caused by Differentiation Alters Intratumoral Drug Distribution and Affects Therapeutic Synergy of Antiangiogenic Organoselenium Compound

Youcef M. Rustum | Károly Tóth | ... | Arup Bhattacharya
  • Special Issue
  • - Volume 2010
  • - Article ID 132641
  • - Review Article

Tumor Angiogenesis: Insights and Innovations

Fernando Nussenbaum | Ira M. Herman
Journal of Oncology
 Journal metrics
Acceptance rate24%
Submission to final decision66 days
Acceptance to publication37 days
CiteScore3.100
Journal Citation Indicator0.680
Impact Factor4.375
 Submit

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.